Skip to main content
. 2015 Oct 9;2015(10):CD010790. doi: 10.1002/14651858.CD010790.pub2

4. Effect of intervention.

  Outcome Farber 1991
(Randomised 174 eyes)
Mean follow up of 42 to 47 months
Jampol 1983
(Randomised 167 eyes)
Mean follow up of 21 to 32 months
Laser (Argon Scatter) Control Laser (Feeder vessel) Control
1 Complete regression of PSR
Partial egression of PSR
30/99 (30.2%)
51/99 (51.0%)
17/75 (22.4%)
18/75 (23.7%)
78/87 (89.6%) Not reported
2 Development of new PSR 34/99 (34.3%) 31/75 (41.3%) Not reported
3 Visual loss 3/99 (3.0%) 9/75 (8.3%) 1/87 (1.14%) 4/80 (5.0 %)
4 Occurrence of vitreous haemorrhage 12/99 (12.0%) 19/75 (25.3%) 3/87 (3.4%) 22/80 (27.5%)
5 Adverse effect: Retinal tear Not reported    
6 Adverse effect: Retinal detachment 3/99 (3.0%) 8/75 (10.6%) 5/87 (5.74%) No event
7 Adverse effect: Choroidal neovascularization Not reported 41/87 (47.12%) No event

Unit of analysis is the eye.

PSR: proliferative sickle retinopathy.

Farber 1991: Mean follow up of 42 months for control group and 47 months for treatment group.

Jampol 1983: Mean follow up of 21 months for Chicago centre and 32 months for Kingston, Jamaica (overall participants).